Regenxbio RGNX Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue (Gross) by Product | |||||
| Nippon Shinyaku Services | $11.82M— | —— | —— | —— | |
| Other Service Revenue | $2.35M+71.9% | $1.37M— | —— | —— | |
| Total Service Revenue | $14.17M+936% | $1.37M— | —— | —— | |
| Revenue by Product | |||||
| License And Service | $156.27M+90.7% | $81.96M-9.2% | $90.24M-19.9% | $112.72M-76.0% | |
| Service | $14.17M+936% | $1.37M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Regenxbio break its business down?
- Regenxbio (RGNX) reports revenue (gross) by product across 4 parts — Nippon Shinyaku Services, Other Service Revenue, Total Service Revenue and Zolgensma And Itvisma Royalties. Each is extracted from the segment footnotes and tracked over time.
- Where does Regenxbio's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Regenxbio's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
